23-valent pneumococcal polysaccharide vaccine (pneumovax-23) Report issue

Active Ingredient History

NOW
  • Now
Pneumococcal polysaccharide vaccine, sold under the brand name Pneumovax 23, is a pneumococcal vaccine that is used for the prevention of pneumococcal disease caused by the 23 serotypes of Streptococcus pneumoniae contained in the vaccine as capsular polysaccharides. It is given by intramuscular or subcutaneous injection.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
1,2,4-trichloro-5-((4-chlorophenyl)sulfinyl)benzene | 23-valent pneumococcal capsular polysaccharide vaccine | 23-valent pneumococcal polysaccharide vaccine | 23-valent ppv | 23-valent vaccine | 23vppv | 2,4,5,4'-tetrachlorodiphenylsulfoxide | pneumo23 | pneumo 23 | pneumo-23 | pneumococcal 23 valent polysaccharide vaccine | pneumococcal polysaccharide vaccine | pneumococcal vaccine, polyvalent | pneumococcal vaccine, polyvalent 23 | pneumovax | pneumovax 23 | pneumovax-23 | pneumovax ii | pnu-imune 23 | polysaccharide anti- pneumococcal vaccine | ppsv23 | ppv-23 | prodiax-23 | tetanus toxoid [tt]-containing adsorbed vaccine | v110

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue